Increasing Lung Transplant Availability Using Normothermic Ex Vivo Lung Perfusion (EVLP) at a Dedicated EVLP Facility
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: End-stage Lung Disease Awaiting Lung Transplant
-
Age: Between 18 years - 120 years
-
Gender: Male or Female
-
Other Inclusion Criteria:
- Informed consent is given for participation in the Study by the patient or patient’s designated representative.
- Patient undergoes lung transplantation.
You may not be eligible for this study if the following are true:
-
- Patients listed for same-side lung re-transplantation.
- Patients listed for multiple-organ transplantation including lung and any other organ.
- Patients listed for live donor lobar lung transplant.
- Patients positive for human immunodeficiency virus (HIV) or Burkholderia cepacia infection.
- Patient receives a standard of care (non-EVLP) lung transplant but does not match to an EVLP subject based on the criteria for control matching.
- Participating in another interventional trial.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.